APA (7th ed.) Citation

Han, X., Liang, L., He, C., Ren, Q., Su, J., Cao, L., & Zheng, J. (2023). A real-world study and network pharmacology analysis of EGFR-TKIs combined with ZLJT to delay drug resistance in advanced lung adenocarcinoma. BMC.

Chicago Style (17th ed.) Citation

Han, Xue, Lan Liang, Chenming He, Qinyou Ren, Jialin Su, Liang Cao, and Jin Zheng. A Real-world Study and Network Pharmacology Analysis of EGFR-TKIs Combined with ZLJT to Delay Drug Resistance in Advanced Lung Adenocarcinoma. BMC, 2023.

MLA (9th ed.) Citation

Han, Xue, et al. A Real-world Study and Network Pharmacology Analysis of EGFR-TKIs Combined with ZLJT to Delay Drug Resistance in Advanced Lung Adenocarcinoma. BMC, 2023.